Highlights

  1. Home
  2. Highlights

Regenity Demonstrates Next-Generation Regenerative Technologies at MEDICA 2025

At MEDICA 2025, Regenity will showcase how its global CDM business model supports the design,…

Read More

Regenity Redefines Medical Device Innovation Via Advanced Contract Development and Manufacturing Expertise, Honored with Prestigious 2025 R&D 100 Award

Regenity Biosciences has been recognized as a winner of the 2025 R&D 100 Awards for its…

Read More

Regenity Expands Global Footprint with NMPA Approval in China

Milestone Marks Another Dental Product Approval in China’s Fast-Growing Regenerative Sector

Read More

Regenity Biosciences Completes First Surgery with RejuvaKnee™, Pioneering Meniscal Repair Innovation

Regenity Biosciences, a global leader in regenerative medicine and Linden Capital Partners…

Read More

Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee™, a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care

PARAMUS, N.J., Oct. 8, 2024 /PRNewswire/ — Regenity Biosciences, a global leader in…

Read More

Regenity Biosciences Receives Regulatory Approval for Collagen Dental Membrane in China After First-of-its-Kind Breakthrough Clinical Study

Multicenter Clinical Study Demonstrates Benefits of Regenity’s Novel Crosslinked Collagen…

Read More

Let’s Connect

Looking for a reliable partner to fill your product portfolio gap, co-create your next great innovation or manufacture your products?
Let’s Connect